标题
The role of CD95 and CD95 ligand in cancer
作者
关键词
-
出版物
CELL DEATH AND DIFFERENTIATION
Volume 22, Issue 4, Pages 549-559
出版商
Springer Nature
发表日期
2015-02-06
DOI
10.1038/cdd.2015.3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- DICE
- (2014) Marcus E Peter CELL CYCLE
- Blockade of Fas Signaling in Breast Cancer Cells Suppresses Tumor Growth and Metastasis via Disruption of Fas Signaling-initiated Cancer-related Inflammation
- (2014) Qiuyan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
- (2014) I Karl et al. Cell Death & Disease
- CD95 and CD95L promote and protect cancer stem cells
- (2014) Paolo Ceppi et al. Nature Communications
- Death Induced by CD95 or CD95 Ligand Elimination
- (2014) Abbas Hadji et al. Cell Reports
- Effects of FasL Expression in Oral Squamous Cell Cancer
- (2013) Li Fang et al. Asian Pacific Journal of Cancer Prevention
- Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer
- (2013) Taofeek K. Owonikoko et al. CANCER
- CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer
- (2013) M. Malleter et al. CANCER RESEARCH
- miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer
- (2013) Haoxuan Zheng et al. CARCINOGENESIS
- Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial–mesenchymal transition in gastrointestinal cancer
- (2013) Haoxuan Zheng et al. EUROPEAN JOURNAL OF CANCER
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- FAS/FASL Expression Profile as a Prognostic Marker in Squamous Cell Carcinoma of the Oral Cavity
- (2013) Paulo Bentes de Carvalho-Neto et al. PLoS One
- CD95 in cancer: tool or target?
- (2013) Ana Martin-Villalba et al. TRENDS IN MOLECULAR MEDICINE
- Is Urinary Soluble Fas an Independent Predictor of Non-Muscle-Invasive Bladder Cancer? A Prospective Chart Study
- (2013) Huixiang Yang et al. UROLOGIA INTERNATIONALIS
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
- (2012) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Fas Ligand Enhances Malignant Behavior of Tumor Cells through Interaction with Met, Hepatocyte Growth Factor Receptor, in Lipid Rafts
- (2012) Huan-Ching Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway
- (2012) Z. Cai et al. JOURNAL OF IMMUNOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fas signaling promotes motility and metastasis through epithelial–mesenchymal transition in gastrointestinal cancer
- (2012) H X Zheng et al. ONCOGENE
- CD95 Is Part of a Let-7/p53/miR-34 Regulatory Network
- (2012) Annika Hau et al. PLoS One
- Fas Expression in Renal Cell Carcinoma Accurately Predicts Patient Survival after Radical Nephrectomy
- (2012) Takehiro Sejima et al. UROLOGIA INTERNATIONALIS
- Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas
- (2011) Stephan Macher-Goeppinger et al. CANCER LETTERS
- The death receptor CD95 activates the cofilin pathway to stimulate tumour cell invasion
- (2011) Ernst J A Steller et al. EMBO REPORTS
- Calmodulin Mediates Fas-induced FADD-independent Survival Signaling in Pancreatic Cancer Cells via Activation of Src-Extracellular Signal-regulated Kinase (ERK)
- (2011) Kaiyu Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Soluble Fas and Fas ligand and prognosis in children with acute lymphoblastic leukemia
- (2011) Mina Fathi et al. MEDICAL ONCOLOGY
- FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
- (2011) Trever G. Bivona et al. NATURE
- The Naturally Processed CD95L Elicits a c-Yes/Calcium/PI3K-Driven Cell Migration Pathway
- (2011) Sébastien Tauzin et al. PLOS BIOLOGY
- Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin’s lymphoma
- (2010) Anastasios Chatzitolios et al. ANNALS OF HEMATOLOGY
- Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells
- (2010) Frederik J.H. Hoogwater et al. GASTROENTEROLOGY
- CD95 is cytoprotective for intestinal epithelial cells in colitis
- (2010) Sun-Mi Park et al. INFLAMMATORY BOWEL DISEASES
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation
- (2010) Maarten W. Nijkamp et al. JOURNAL OF HEPATOLOGY
- Tumor promoting effects of CD95 signaling in chemoresistant cells
- (2010) Elisabet Ametller et al. Molecular Cancer
- mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
- (2010) Robert Schickel et al. MOLECULAR CELL
- CD95 promotes tumour growth
- (2010) Lina Chen et al. NATURE
- Breast cancer stem cells: tools and models to rely on
- (2009) Emmanuelle Charafe-Jauffret et al. BMC CANCER
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
- (2009) Yohei Shimono et al. CELL
- The Death Receptor CD95 Activates Adult Neural Stem Cells for Working Memory Formation and Brain Repair
- (2009) Nina S. Corsini et al. Cell Stem Cell
- Human and Mouse Colon Cancer Utilizes CD95 Signaling for Local Growth and Metastatic Spread to Liver
- (2009) Hanchen Li et al. GASTROENTEROLOGY
- The Many Roles of FAS Receptor Signaling in the Immune System
- (2009) Andreas Strasser et al. IMMUNITY
- Expression of Fas and Fas ligand in human testicular germ cell tumours
- (2009) E. Baldini et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE2
- (2009) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
- (2009) Lorraine A. O’ Reilly et al. NATURE
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasminogen Activator Inhibitor-1 Protects Endothelial Cells from FasL-Mediated Apoptosis
- (2008) Khalid Bajou et al. CANCER CELL
- Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
- (2008) Susanne Kleber et al. CANCER CELL
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- CD95 Ligand Is a Proliferative and Antiapoptotic Signal in Quiescent Hepatic Stellate Cells
- (2008) Roland Reinehr et al. GASTROENTEROLOGY
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now